SALA, LUCA
 Distribuzione geografica
Continente #
NA - Nord America 4.607
AS - Asia 3.593
EU - Europa 2.418
SA - Sud America 483
AF - Africa 90
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 3
Totale 11.198
Nazione #
US - Stati Uniti d'America 4.416
SG - Singapore 1.227
VN - Vietnam 742
CN - Cina 721
IT - Italia 589
RU - Federazione Russa 414
BR - Brasile 370
HK - Hong Kong 351
DE - Germania 350
IE - Irlanda 169
SE - Svezia 158
CA - Canada 138
GB - Regno Unito 136
PL - Polonia 117
FR - Francia 116
IN - India 115
BD - Bangladesh 82
UA - Ucraina 82
KR - Corea 76
ID - Indonesia 67
FI - Finlandia 63
NL - Olanda 49
AR - Argentina 45
AT - Austria 44
DK - Danimarca 38
ZA - Sudafrica 35
JP - Giappone 32
TR - Turchia 31
IQ - Iraq 28
ES - Italia 26
MX - Messico 25
EC - Ecuador 23
PK - Pakistan 19
SA - Arabia Saudita 16
UZ - Uzbekistan 16
PH - Filippine 15
CH - Svizzera 14
VE - Venezuela 13
CO - Colombia 12
BE - Belgio 11
LT - Lituania 11
MA - Marocco 11
MY - Malesia 9
CL - Cile 8
AE - Emirati Arabi Uniti 6
DO - Repubblica Dominicana 6
JO - Giordania 6
SN - Senegal 6
BG - Bulgaria 5
CR - Costa Rica 5
EG - Egitto 5
KE - Kenya 5
PE - Perù 5
DZ - Algeria 4
ET - Etiopia 4
EU - Europa 4
IR - Iran 4
JM - Giamaica 4
OM - Oman 4
PT - Portogallo 4
RO - Romania 4
AO - Angola 3
AZ - Azerbaigian 3
NG - Nigeria 3
NO - Norvegia 3
NP - Nepal 3
PA - Panama 3
PY - Paraguay 3
TH - Thailandia 3
TN - Tunisia 3
UY - Uruguay 3
AL - Albania 2
BA - Bosnia-Erzegovina 2
CI - Costa d'Avorio 2
CU - Cuba 2
CY - Cipro 2
CZ - Repubblica Ceca 2
IL - Israele 2
KW - Kuwait 2
LB - Libano 2
MN - Mongolia 2
MT - Malta 2
NA - Namibia 2
NZ - Nuova Zelanda 2
PR - Porto Rico 2
QA - Qatar 2
RS - Serbia 2
SC - Seychelles 2
AG - Antigua e Barbuda 1
AU - Australia 1
BH - Bahrain 1
CG - Congo 1
DJ - Gibuti 1
DM - Dominica 1
EE - Estonia 1
GA - Gabon 1
GE - Georgia 1
GR - Grecia 1
GT - Guatemala 1
GY - Guiana 1
Totale 11.187
Città #
Singapore 755
San Jose 596
Ashburn 497
Ann Arbor 492
Hong Kong 341
Ho Chi Minh City 226
Woodbridge 203
Wilmington 191
Hanoi 179
Fairfield 176
Dublin 161
Milan 155
Hefei 148
Frankfurt am Main 144
New York 143
Houston 140
Chandler 115
Santa Clara 112
Beijing 96
Dallas 94
Kraków 94
Los Angeles 87
Seattle 85
Dearborn 83
Chicago 82
Seoul 73
Cambridge 65
Boardman 62
Jacksonville 60
Toronto 55
Jakarta 51
São Paulo 50
The Dalles 49
Moscow 47
Council Bluffs 42
Buffalo 41
Lauterbourg 39
Da Nang 36
Vienna 35
Shanghai 33
Princeton 32
Nanjing 29
Helsinki 28
Chennai 27
Rome 27
Dong Ket 26
Orem 26
Tokyo 25
Haiphong 24
Warsaw 23
Denver 22
Johannesburg 19
Montreal 19
Munich 18
Atlanta 16
Padova 15
Stockholm 15
Altamura 14
Brooklyn 14
Hyderabad 14
Lawrence 14
Ottawa 14
Tashkent 14
Amsterdam 13
Hải Dương 13
Lappeenranta 13
Nanchang 13
Tianjin 13
Vũng Tàu 13
Manchester 12
Nuremberg 12
Phoenix 12
Quận Bình Thạnh 12
Salt Lake City 12
Biên Hòa 11
Can Tho 11
Hebei 11
London 11
Poplar 11
Turku 11
Brussels 10
Mumbai 10
Rio de Janeiro 10
Torino 10
Baghdad 9
Bắc Ninh 9
Campinas 9
Fremont 9
Guangzhou 9
Guayaquil 9
Jinan 9
Lachine 9
Mexico City 9
Montréal 9
Pune 9
Trieste 9
Turin 9
Zurich 9
Brasília 8
Changsha 8
Totale 6.994
Nome #
MTMR4 SNVs modulate ion channel degradation and clinical severity in congenital long QT syndrome: insights in the mechanism of action of protective modifier genes 496
Elucidating arrhythmogenic mechanisms of long-QT syndrome CALM1-F142L mutation in patient-specific induced pluripotent stem cell-derived cardiomyocytes 477
Action potential contour contributes to species differences in repolarization response to b-adrenergic stimulation 472
Calmodulinopathy: A Novel, Life-Threatening Clinical Entity Affecting the Young 450
Therapeutic Efficacy of Mexiletine for Long QT Syndrome Type 2: Evidence from Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes, Transgenic Rabbits, and Patients 445
Prevention of myocardial remodeling by chronic INaL blockade in pulmonary hypertension 411
Ranolazine prevents INaL enhancement and blunts myocardial remodelling in a model of pulmonary hypertension 403
Late sodium current (INaL) in pancreatic β-cells 386
Altered functional differentiation of mesoangioblasts in a genetic myopathy 383
From patient-specific induced pluripotent stem cells to clinical translation in long QT syndrome Type 2 378
Calmodulinopathy: Functional Effects of CALM Mutations and Their Relationship With Clinical Phenotypes 351
Aberrant Functional Differentiation of Cardiac Precursors from a Dystrophic Mouse 349
IKr Impact on Repolarization and Its Variability Assessed by Dynamic Clamp 343
Post-natal cardiomyocytes can generate iPS cells with an enhanced capacity toward cardiomyogenic re-differentation 319
The Dynamic Clamp Technique: A Robust Toolkit for Investigating Potassium Channel Function 318
Membrane-targeted push-pull azobenzenes for the optical modulation of membrane potential 296
Musclemotion: A versatile open software tool to quantify cardiomyocyte and cardiac muscle contraction in vitro and in vivo 269
Identification and functional characterisation of a new KCNJ2 mutation 259
Long QT Syndrome modelled with human induced pluripotent stem cells (hiPSc) 249
A dynamic clamping approach using in silico IK1 current for discrimination of chamber-specific hiPSC-derived cardiomyocytes 235
Generation and characterization of the human induced pluripotent stem cell (hiPSC) line NCUFi001-A from a patient carrying KCNQ1 G314S mutation 235
Clinical presentation of calmodulin mutations: the International Calmodulinopathy Registry 210
The impact of genetics on the long QT syndrome: myth or reality? 186
Geneless optomodulation of cardiomyocytes membrane potential by sarcolemma-targeted azobenzene photoswitches 185
Multiplexed Assays of Variant Effect and Automated Patch Clamping Improve KCNH2-LQTS Variant Classification and Cardiac Event Risk Stratification 181
Use of hiPSC-Derived Cardiomyocytes to Rule Out Proarrhythmic Effects of Drugs: The Case of Hydroxychloroquine in COVID-19 179
Use of hiPSC-derived cardiomyocytes to study LQTS-variant specific proarrhythmic effects of drugs 172
Gene- and variant-specific efficacy of serum/glucocorticoid-regulated kinase 1 inhibition in long QT syndrome types 1 and 2 166
Human Induced Pluripotent Stem Cells-Derived Cardiomyocytes Carrying CALM1-F142l Mutation Recapitulate LQTS Phenotype in Vitro 165
Cardiac microtissues from human pluripotent stem cells recapitulate the phenotype of long-QT syndrome 163
Cardiomyocyte and stromal cell cross-talk influences the pathogenesis of arrhythmogenic cardiomyopathy: a multi-level analysis uncovers DLK1-NOTCH pathway role in fibro-adipose remodelling 160
Geneless optomodulation of cardiomyocytes membrane potential by membrane-targeted azobenzene photoswitches 154
Continuous Bayesian Variant Interpretation Accounts for Incomplete Penetrance among Mendelian Cardiac Channelopathies 153
Estimating the Posttest Probability of Long QT Syndrome Diagnosis for Rare KCNH2 Variants 151
Rescue of loss-of-function long QT syndrome-associated mutations in KV7.1/KCNE1 by the endocannabinoid N-arachidonoyl-L-serine (ARA-S) 142
Precision Medicine and cardiac channelopathies: When dreams meet reality 136
Advances in pluripotent stem cell-based in vitro models of the human heart for cardiac physiology, disease modeling and clinical applications 135
Three-dimensional cardiac microtissues composed of cardiomyocytes and endothelial cells co-differentiated from human pluripotent stem cells 126
Electrophysiological analysis of human pluripotent stem cell-derived cardiomyocytes (hPSC-CMs) using multi-electrode arrays (MEAs) 125
Human-iPSC-Derived Cardiac Stromal Cells Enhance Maturation in 3D Cardiac Microtissues and Reveal Non-cardiomyocyte Contributions to Heart Disease 125
Cardiac Repolarization and Stem Cells: An Emerging Path Toward Precision Medicine 113
A new hERG allosteric modulator rescues genetic and drug-induced long-QT syndrome phenotypes in cardiomyocytes from isogenic pairs of patient induced pluripotent stem cells 112
Quantification of Muscle Contraction In Vitro and In Vivo Using MUSCLEMOTION Software: From Stem Cell-Derived Cardiomyocytes to Zebrafish and Human Hearts 111
Integrating cardiomyocytes from human pluripotent stem cells in safety pharmacology: has the time come? 107
Isogenic Sets of hiPSC-CMs Harboring Distinct KCNH2 Mutations Differ Functionally and in Susceptibility to Drug-Induced Arrhythmias 105
Long QT Syndrome modelling with cardiomyocytes derived from human-induced pluripotent stem cells 103
Simultaneous measurement of excitation-contraction coupling parameters identifies mechanisms underlying contractile responses of hiPSC-derived cardiomyocytes 100
Precision versus traditional medicine - Clinical questions trigger progress in basic science: A favor not always returned 87
Perioperative Chemo/Immunotherapies in Lung Cancer: A Critical Review on the Value of Perioperative Sequences 77
A platform for assessing pro- and anti-arrhythmic effects of drugs based on isogenic human iPSC-derived cardiomyocytes 64
null 29
Totale 11.546
Categoria #
all - tutte 35.510
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.510


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202158 0 0 0 0 0 0 0 0 0 0 0 58
2021/2022327 25 38 33 24 10 32 15 17 19 36 28 50
2022/2023632 63 162 52 54 24 70 15 88 60 13 21 10
2023/2024694 13 18 34 41 80 167 127 45 70 22 13 64
2024/20252.213 74 215 218 71 139 85 124 89 167 351 174 506
2025/20265.219 673 434 341 596 588 245 913 220 386 433 234 156
Totale 11.546